SEC Form 4 · accession 0001140361-18-041597
BALCHEM CORP · BALCHEM CO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Theresa Coelho
Officer — Chief Financial Officer
Period of report
Oct 26, 2018
Accepted (ET)
Oct 30, 2018 · 10:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000009326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 29, 2018 | F | 1,187 | $96.42 | D | 2,105 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $74.57 | Oct 26, 2018 | A | 1,132 | A | Oct 26, 2018 | Feb 15, 2028 | Common Stock | 1,132 | 3,337 | D |
Explanation of responses
- F1The Company granted 5,605 restricted shares under the Company's Long-Term Incentive Program. The shares were subject to certain restrictions under the applicable Restricted Stock Grant Agreements. 1,187 of the 3,210 shares that vested October 26, 2018 were withheld to cover withholding taxes due upon vesting.
- F2In connection with a Separation Agreement and General Release (SA&GR) between the Company and the reporting person, 1,050 shares previously reported as beneficially owned in connection with Restricted Stock Grant Agreements were forfeited.
- F3On February 15, 2018, the reporting person was granted an option to purchase 5,030 shares of common stock scheduled to vest in installments of 20%, 40%, and 40% per year over the three-year period. The option reported herein as acquired resulted from the acceleration of vesting of 22.5% of such option in connection with a SA&GR.